+49 711 500 989 80
deen

A potential new target for cancer immunotherapies



A potential new target for cancer immunotherapies

Tumors can use an enzyme called ART1 to thwart antitumor immune cells, making the enzyme a promising new target for immunity-boosting cancer treatments, according to a new study.

Materials provided by Weill Cornell Medicine. Note: Content may be edited for style and length.




Source link aaaaa

Related posts

27th May 2022

High cost of cancer care in the U.S. doesn't reduce mortality rates

Read more
27th May 2022

T cell warriors need their R & R

Read more
27th May 2022

New cancer subtype may illuminate treatment strategy

Read more